chief executive officer stresses, nonetheless, that the firm will certainly not be leaping via hoops.
发布者：BY CHRISTOPHER DUE KARLSSON，转转请注明出处：https://robotalks.cn/zealand-pharma-weighing-options-to-market-obesity-drug-faster-after-roche-deal/
Zealand Pharma weighing options to market obesity drug faster after Roche deal
赞 (0)
关于作者
WSA CEO: Product launches will compensate for tough market
上一篇
10 5 月, 2025 7:19 下午
Genmab maintains guidance despite 30% growth in Darzalex sales
下一篇
10 5 月, 2025 7:19 下午
相关推荐
-
Akorfa Dagadu named 2027 Schwarzman Scholar
MIT undergraduate Akorfa Dagadu has actually been called a Schwarzman Scholar and will certainly sign up with the program’s Course of 2026-27 scholars from 40 nations and 83 …
-
KFSHRC advances smart hospital transformation through AI and emerging technologies
King Faisal Expert Health Center & Research Study Centre (KFSHRC) is establishing a high requirement for international health care with its Smart Health center campaign, lever…
-
Insights from satellite data pave the way to better solar power generation
Among the continuous power situation and under the danger of environment modification, manipulating renewable resource resources has rapidly end up being a worldwide requirement. T…
-
Inside China’s push to apply AI across its energy system
Under China’s press to tidy up its power system, AI is beginning to form just how power is created, relocated, and made use of– not in abstract plan terms, however in d…
-
Aeva Announces Date for Fourth Quarter and Full Year 2025 Results and Conference Call
MOUNTAIN VIEW, Calif.–(BUSINESS WIRE)–Aeva® (Nasdaq: AEVA), a pacesetter in next-generation sensing and notion techniques, right this moment introduced it’s going…
